Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pseudomyxoma Peritonei × Alemtuzumab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 52 Leukemia 45 Lymphoma 34 Myelodysplastic Syndromes 21 Lymphoma, Non-Hodgkin 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Hodgkin Disease 19 Leukemia, Myeloid, Acute 15 Multiple Myeloma 14 Myeloproliferative Disorders 13 Recurrence 10 Lymphoma, Mantle-Cell 10 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Follicular 9 Hematologic Neoplasms 9 Anemia, Aplastic 9 Lymphoma, T-Cell, Peripheral 8 Leukemia, Myeloid, Chronic-Phase 8 Congenital Abnormalities 8 Burkitt Lymphoma 8 Neoplasms, Plasma Cell 7 Lymphoma, B-Cell, Marginal Zone 7 Sezary Syndrome 6 Primary Myelofibrosis 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Mycosis Fungoides 6 Lymphoma, T-Cell, Cutaneous 6 Lymphoma, T-Cell 6 Lymphoma, Large-Cell, Immunoblastic 6 Leukemia, Myelomonocytic, Chronic 6

Interventions

Mitomycin 3 Hyperthermic Intraperitoneal Chemotherapy 2 Capecitabine 2 tislelizumab 1 molgramostim 1 irinotecan sucrosofate 1 cryoprecipitate coagulum 1 Tacrolimus 1 Surveys and Questionnaires 1 Specimen Handling 1 Sirolimus 1 Radiosurgery 1 Psychiatric Rehabilitation 1 Pharmacogenomic Testing 1 Oxaliplatin 1 Nivolumab 1 Methods 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Lansoprazole 1 Ipilimumab 1 Gemcitabine 1 Fluorouracil 1 Floxuridine 1 Early Intervention, Educational 1 Cytoreduction Surgical Procedures 1 Clarithromycin 1 Carboplatin 1 CTLA-4 Antigen 1 Bromelains 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06084780 2026-01-23

TRANSCAPE

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡